Dolby Laboratories
(DLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2010 | 09-2009 | 09-2008 | 09-2007 | 09-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 282,827 | 244,346 | 201,032 | 142,831 | 89,549 |
| Depreciation Amortization | 44,055 | 34,321 | 26,718 | 12,130 | 12,862 |
| Income taxes - deferred | -16,031 | 5,237 | -21,750 | -33,119 | -18,694 |
| Accounts receivable | -31,329 | 1,797 | 987 | -5,012 | 1,289 |
| Other Working Capital | 1,573 | -9,137 | 59,254 | 43,245 | 44,218 |
| Other Operating Activity | 46,203 | -3,339 | -1,767 | 2,898 | 3,278 |
| Operating Cash Flow | $327,298 | $273,225 | $264,474 | $162,973 | $132,502 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35,322 | -13,994 | -13,570 | -10,578 | -8,039 |
| Net Acquisitions | -5,601 | -16,621 | -253,047 | -30,208 | N/A |
| Purchase Of Investment | -646,052 | -373,223 | -304,097 | -427,825 | -438,295 |
| Sale Of Investment | 643,443 | 176,908 | 299,376 | 280,941 | 283,980 |
| Purchase Sale Intangibles | -825 | -9,571 | N/A | -5,225 | N/A |
| Other Investing Activity | -825 | -9,571 | 0 | -5,127 | -1,044 |
| Investing Cash Flow | $-44,357 | $-236,501 | $-271,338 | $-192,797 | $-163,398 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7,680 | -1,522 | -1,536 | -1,467 | -1,360 |
| Common Stock Issued | 42,398 | 17,218 | 14,686 | 10,146 | 7,717 |
| Common Stock Repurchased | -241,362 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 21,870 | 5,827 | 21,746 | 21,845 | 13,845 |
| Financing Cash Flow | $-184,774 | $21,523 | $34,896 | $30,524 | $20,202 |
| Exchange Rate Effect | -3,984 | -1,330 | -1,738 | 4,230 | 1,828 |
| Beginning Cash Position | 451,678 | 394,761 | 368,467 | 363,537 | 372,403 |
| End Cash Position | 545,861 | 451,678 | 394,761 | 368,467 | 363,537 |
| Net Cash Flow | $94,183 | $56,917 | $26,294 | $4,930 | $-8,866 |
| Free Cash Flow | |||||
| Operating Cash Flow | 327,298 | 273,225 | 264,474 | 162,973 | 132,502 |
| Capital Expenditure | -37,482 | -13,994 | -13,610 | -10,578 | -8,039 |
| Free Cash Flow | 289,816 | 259,231 | 250,864 | 152,395 | 124,463 |